Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
Registered number: 7114723 Charity number: 1134995
FOUNDATION OF EUROPEAN NURSES IN DIABETES
(A Company Limited by Guarantee)
UNAUDITED
TRUSTEES' REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
| CONTENTS | |
|---|---|
| Page | |
| Reference and Administrative Details of the Charity, its Trustees and Advisers | 1 - 2 |
| Trustees' Report | 3 - 6 |
| Independent Examiner's Report | 7 |
| Statement of Financial Activities | 8 |
| Balance Sheet | 9 |
| Notes to the Financial Statements | 10 - 21 |
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2023
Trustees
Kristin de Backer Deirdre Cregan Chris Delicata Anne-Marie Felton Deirdre Kyne-Grzebalski Prof Regina Wredling RN, Dr Med Sc
Company registered number
7114723
Charity registered number
1134995
Registered office
37 Earl's Drive Newcastle upon Tyne NE15 7AL
Accountants
Kinnair Associates Limited Chartered Accountants Aston House Redburn Road Newcastle upon Tyne NE5 1NB
Bankers
Barclays Bank plc Leicester
Close Brothers Savings 10 Crown Place London
Members of the Executive Committee
Kristin de Backer (Chairman) Rita Forde (Secretary) Anne-Marie Felton (President) Ana Paiva (Membership Secretary) Deirdre Kyne-Grzebalski (Treasurer) Davide Ausili Eugenia Viachou Rahab Hashim
Abstract Committee
Unn-Britt Johansson
Page 1
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023
Special Advisors
Els Denis RN Prof Sally Marshall BSc MB MD Assoc Prof Seyda Ozcan RN PhD Prof Regina Wredling RN, Dr Med Sc
Honorary Members
Deirdre Cregan Dr Michael Hall Sue Hamilton Stina Wallenkrans Prof Regina Wredling RN, Dr Med Sc
EDN Journal Editor
Davide Ausili
Website
www.fend.org
Page 2
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2023
The Trustees present their annual report together with the financial statements of the charity for the year from 1 January 2023 to 31 December 2023. The Annual Report serves the purposes of both a Trustees' report and a directors' report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).
Since the charity qualifies as small under section 382 of the Companies Act 2006, the Strategic Report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.
Objectives and activities
Policies and objectives
In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance 'Public benefit: running a charity (PB2)'.
The objects for which FEND is established are:
-
to promote for the public benefit improvements in the health and treatment of sufferers from diabetes by the development and promotion of the role of the diabetes nurse specialist throughout Europe: and
-
to promote, for the public benefit, the education and training of nurses working in diabetes care throughout Europe by the development and support of training programmes, including the organisation of conferences and symposia, to further such programmes and the dissemination of information relating to the proceedings at such conferences or symposia.
Achievements and performance
Main achievements of the charity
Professional Support
A Virtual Annual Conference continues to be organised over two days providing up to date information on many aspects of Diabetes.
The European Nurses Collaborative Universities Programme (ENDCUP) is continuing for nurses specialising in Diabetes from the whole of Europe. It is accredited by King's College University and funded by FEND.
An online Journal is available for all Nurses specialising in Diabetes.
Public Good
FEND continues to collaborate with Pan European organisations including the International Federation Europe (IDF) and as an equal partner in the European Coalition on Diabetes (ECD).
Page 3
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023
Financial review
Financial overview
The charity's incoming resources decreased from £85,777 to £67,781. Total resources expended increased from £150,964 to £279,313. Net outgoing resources for the year amounted to £211,532 (2022 - net outgoing resources: £65,187).
The Trustees carry out an annual review of the level of income reserves which they feel is appropriate to maintain in order to meet the charity's objectives effectively. The charity held fund balances at the year end of £930,163, all of which were unrestricted funds and held in forms considered appropriate to the charitable company's activities and future commitments.
Reserves policy
The free reserves of the charity at 31 December 2023 were £928,930 (2022: £1,140,052).
The Board of Trustees have agreed that it is necessary to maintain a level of reserves to cover the annual administrative costs to the Charity and the final expenditure for two PhD students. This amounts to £100,000 until the end of 2024. The Trustees are pleased to note that the total funds exceed this figure and plan to use these monies when the Charity resumes annual face to face conferences in different venues across Europe. This has always been our biggest outgoing, until the Covid restrictions were put in place and we could not meet together or travel to appropriate venues.
The FEND MSc Programme continues and is highly valued by our membership. The course is validated and implemented by the Florence Nightingale Faculty of Nursing and funded by FEND.
Going concern
After making appropriate enquiries, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the accounting policies.
Principal risks and uncertainties
The Trustees have identified the principal risks facing the charity and, in their opinion, have addressed those risks by appointment of informed Trustees who can provide detailed and appropriate guidance to all other officers, and by the appointment of external independent examiners.
Structure, governance and management
Constitution
Foundation of European Nurses in Diabetes is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association. The relevant governing document is the Memorandum and Articles of Association.
Page 4
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023
Structure, governance and management (continued)
Methods of appointment or election of Trustees
The management of the charity is the responsibility of the Trustees who are elected and co-opted under the terms of the Memorandum of Association.
New Trustees are appointed by the serving Trustees.
Policies adopted for the induction and training of Trustees
The training and induction provided for new Trustees is provided by the serving Trustees.
Plans for future periods
The Diabetes Clinical Care and Management MSc Programme will continue funded by FEND.
No further PhD Programmes will be funded by FEND.
Members' liability
The Members of the charity guarantee to contribute an amount not exceeding £10 to the assets of the charity in the event of winding up.
Statement of Trustees' responsibilities
The Trustees (who are also the directors of the charity for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).
Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:
-
select suitable accounting policies and then apply them consistently;
-
observe the methods and principles of the Charities SORP (FRS 102);
-
make judgments and accounting estimates that are reasonable and prudent;
-
state whether applicable UK Accounting Standards (FRS 102) have been followed, subject to any material departures disclosed and explained in the financial statements;
-
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charity will continue in business.
Page 5
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023
Statement of Trustees' responsibilities (CONTINUED)
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Approved by order of the members of the board of Trustees on 9 September 2024 and signed on their behalf by:
Deirdre Kyne-Grzebalski
Page 6
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2023
Independent Examiner's Report to the Trustees of Foundation of European Nurses in Diabetes ('the charity')
I report to the charity Trustees on my examination of the accounts of the charity for the year ended 31 December 2023.
Responsibilities and Basis of Report
As the Trustees of the charity (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the charity's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.
Independent Examiner's Statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
-
accounting records were not kept in respect of the charity as required by section 386 of the 2006 Act; or
-
the accounts do not accord with those records; or
-
the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or
-
the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
This report is made solely to the charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the charity's Trustees those matters I am required to state to them in an Independent Examiner's Report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the charity and the charity's Trustees as a body, for my work or for this report.
Signed: Dated: 9 September 2024 Mai Mak FCA
Kinnair Associates Limited Chartered Accountants Aston House Redburn Road Newcastle upon Tyne NE5 1NB
Page 7
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES
(A Company Limited by Guarantee)
STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2023
| Note Income from: Donations and legacies 3 Charitable activities 4 Investments 5 Total income Expenditure on: Charitable activities 7 Total expenditure Net movement in funds Reconciliation of funds: Total funds brought forward Net movement in funds Total funds carried forward |
Unrestricted funds 2023 £ 43,478 4,151 20,152 67,781 279,313 279,313 (211,532) 1,141,695 (211,532) 930,163 |
Total funds 2023 £ 43,478 4,151 20,152 67,781 279,313 279,313 (211,532) 1,141,695 (211,532) 930,163 |
Total funds 2022 £ 78,255 3,481 4,041 85,777 150,964 150,964 (65,187) 1,206,882 (65,187) 1,141,695 |
|---|---|---|---|
The Statement of Financial Activities includes all gains and losses recognised in the year.
The notes on pages 10 to 21 form part of these financial statements.
Page 8
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee) REGISTERED NUMBER: 7114723
BALANCE SHEET AS AT 31 DECEMBER 2023
| Note Fixed assets Tangible assets 12 Current assets Debtors 13 Cash at bank and in hand Creditors: amounts falling due within one year 14 Net current assets Total net assets Charity funds Unrestricted funds 16 Total funds |
10,370 922,442 932,812 (3,882) |
2023 £ 1,233 1,233 928,930 930,163 930,163 930,163 |
3,463 1,157,700 1,161,163 (21,111) |
2022 £ 1,643 |
|---|---|---|---|---|
| 1,643 1,140,052 |
||||
| 1,141,695 | ||||
| 1,141,695 | ||||
| 1,141,695 |
The charity was entitled to exemption from audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.
The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.
The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.
The financial statements were approved and authorised for issue by the Trustees on 09 September 2024 and signed on their behalf by:
Deirdre Kyne-Grzebalski
The notes on pages 10 to 21 form part of these financial statements.
Page 9
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
1. General information
The Foundation of European Nurses in Diabetes (FEND, the charity, the charitable company) is a charitable company formed to help nurses working in the field of diabetes care, research and education in Europe. It is a private company limited by guarantee incorporated in England and Wales, (registered number 7114723) and is also a registered charity (registration number 1134995).
The Trustees who acted during the year and up to the date of the Trustees report are shown on page 1.
The registered office of the charity and details of its principal advisers are shown on page 1.
2. Accounting policies
2.1 Basis of preparation of financial statements
The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
Foundation of European Nurses in Diabetes meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.
2.2 Going concern
After making appropriate enquiries and taking into consideration the potential impact of the Covid pandemic, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements.
2.3 Income
All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.
Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.
2.4 Expenditure
Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources.
Page 10
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
2. Accounting policies (continued)
2.4 Expenditure (continued)
Expenditure on charitable activities is incurred on directly undertaking the activities which further the charity's objectives, as well as any associated support costs.
All expenditure is inclusive of irrecoverable VAT.
2.5 Interest receivable
Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.
2.6 Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at rates of exchange ruling at the reporting date.
Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction.
Exchange gains and losses are recognised in the Statement of Financial Activities.
2.7 Taxation
The charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.
2.8 Tangible fixed assets and depreciation
Tangible fixed assets costing £500 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.
Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.
Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives.
Depreciation is provided on the following basis:
Office equipment - 25% straight line
Page 11
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
2. Accounting policies (continued)
2.9 Debtors
Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.
2.10 Cash at bank and in hand
Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.
2.11 Liabilities and provisions
Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.
Liabilities are recognised at the amount that the charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.
Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.
2.12 Financial instruments
The charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.
2.13 Fund accounting
General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the charity and which have not been designated for other purposes.
Investment income, gains and losses are allocated to the appropriate fund.
Page 12
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
3. Income from donations and legacies
| Unrestricted funds 2023 £ Sponsorship 43,478 Unrestricted funds 2022 £ Sponsorship 78,255 |
Total funds 2023 £ 43,478 |
|---|---|
| Total funds 2022 £ 78,255 |
| 4. Income from charitable activities Unrestricted funds 2023 £ Members' subscriptions 4,151 Unrestricted funds 2022 £ Members' subscriptions 3,481 |
Total funds 2023 £ 4,151 |
|---|---|
| Total funds 2022 £ 3,481 |
| 5. | Investment income | ||
|---|---|---|---|
| Unrestricted | Total | ||
| funds | funds | ||
| 2023 | 2023 | ||
| £ | £ | ||
| Bank interest receivable | 20,152 | 20,152 |
Page 13
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
5. Investment income (continued)
| Unrestricted | Total | |
|---|---|---|
| funds | funds | |
| 2022 | 2022 | |
| £ | £ | |
| Bank interest receivable | 4,041 | 4,041 |
6. Analysis of grants
| Grants and donations Grants and donations |
Grants to Institutions 2023 £ 240,783 Grants to Institutions 2022 £ 184,348 |
Total funds 2023 £ 240,783 |
|---|---|---|
| Total funds 2022 £ 184,348 |
The charity has made the following material grants to institutions during the year:
| Name of institution IDF Europe King's College London - FEND Fellowship King's College London - ENDCUP Other grants to institutions |
2023 £ 4,348 100,000 136,000 435 240,783 |
2022 £ 4,348 100,000 80,000 - |
|---|---|---|
| 184,348 |
Page 14
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
7. Analysis of expenditure on charitable activities
Summary by fund type
| Unrestricted funds 2023 £ Direct costs - Training and education 279,313 Unrestricted funds 2022 £ Direct costs - Training and education 150,964 |
Total 2023 £ 279,313 |
|---|---|
| Total 2022 £ 150,964 |
8. Analysis of expenditure by activities
| Direct costs - Training and education Direct costs - Training and education |
Activities undertaken directly 2023 £ 7,208 Activities undertaken directly 2022 £ 6,981 |
Grant funding of activities 2023 £ 240,783 Grant funding of activities 2022 £ 184,348 |
Support costs 2023 £ 31,322 Support costs 2022 £ (40,365) |
Total funds 2023 £ 279,313 |
|---|---|---|---|---|
| Total funds 2022 £ 150,964 |
Page 15
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
8. Analysis of expenditure by activities (continued)
Analysis of direct costs
| Travel and subsistence Journal publishing costs Journal publishing costs Analysis of support costs Legal and professional costs Office and administration costs Foreign currency losses Depreciation Governance costs |
Training and education 2023 £ 4,866 2,342 7,208 Training and education 2022 £ 6,981 Training and education 2023 £ 706 1,296 25,028 410 3,882 31,322 |
Total funds 2023 £ 4,866 2,342 |
|---|---|---|
| 7,208 | ||
| Total funds 2022 £ 6,981 |
||
| Total funds 2023 £ 706 1,296 25,028 410 3,882 |
||
| 31,322 |
Page 16
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
8. Analysis of expenditure by activities (continued)
Analysis of support costs (continued)
| Staff costs Legal and professional costs Office and administration costs Foreign currency gains Depreciation Governance costs |
Training and education 2022 £ 300 661 4,512 (50,080) 546 3,696 (40,365) |
Total funds 2022 £ 300 661 4,512 (50,080) 546 3,696 |
|---|---|---|
| (40,365) |
Governance costs above comprise accountancy and independent examination costs.
9. Independent examiner's remuneration
| 2023 | 2022 | |
|---|---|---|
| £ | £ | |
| Fees payable to the charity's independent examiner for the preparation and | ||
| independent examination of the charity's annual accounts | 3,235 | 3,080 |
| Fees payable to the charity's independent examiner in respect of: | ||
| All other services | 588 | 551 |
10. Staff costs
| 2023 | 2022 | |
|---|---|---|
| £ | £ | |
| Wages and salaries | - | 300 |
The average number of persons employed by the charity during the year was 1 (2020: 1).
No employee received remuneration amounting to more than £60,000 in either year.
Page 17
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
11. Trustees' remuneration and expenses
During the year, no Trustees received any remuneration or other benefits (2022 - £NIL) .
During the year ended 31 December 2023, expenses totalling £ 1,747 were reimbursed or paid directly to 2 Trustees (2022 - £1,004 to 2 Trustees) . These were for travel, telephone and other office expenditure.
12. Tangible fixed assets
| Cost or valuation At 1 January 2023 At 31 December 2023 Depreciation At 1 January 2023 Charge for the year At 31 December 2023 Net book value At 31 December 2023 At 31 December 2022 |
Office equipment £ 7,139 |
|---|---|
| 7,139 | |
| 5,496 410 |
|
| 5,906 | |
| 1,233 | |
| 1,643 |
13. Debtors
| Due within one year Prepayments and accrued income |
2023 £ 10,370 10,370 |
2022 £ 3,463 3,463 |
|---|---|---|
Page 18
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
14. Creditors: Amounts falling due within one year
| Other taxation and social security Accruals and deferred income |
2023 £ - 3,882 3,882 |
2022 £ 24 21,087 |
|---|---|---|
| 21,111 |
Accruals and deferred income includes £nil (2022: £17,391) funding received in advance for the following financial year.
15. Financial instruments
| 2023 | 2022 | |
|---|---|---|
| £ | £ | |
| Financial assets | ||
| Financial assets measured at fair value through income and expenditure | 922,442 | 1,157,700 |
Financial assets measured at fair value through income and expenditure comprise bank balances.
Page 19
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
16. Statement of funds
Statement of funds - current year
| Balance at 1 January 2023 £ Unrestricted funds General Funds 1,141,695 Statement of funds - prior year Balance at 1 January 2022 £ Unrestricted funds General Funds 1,206,882 |
Income £ Expenditure £ 67,781 (279,313) Income £ Expenditure £ 85,777 (150,964) |
Balance at 31 December 2023 £ 930,163 |
|---|---|---|
| Balance at 31 December 2022 £ 1,141,695 |
17. Analysis of net assets between funds
Analysis of net assets between funds - current year
| Unrestricted funds 2023 £ Tangible fixed assets 1,233 Current assets 932,812 Creditors due within one year (3,882) Total 930,163 |
Total funds 2023 £ 1,233 932,812 (3,882) |
|---|---|
| 930,163 |
Page 20
Docusign Envelope ID: F9E77866-9ACE-4A3F-899F-426DF8593A1D
FOUNDATION OF EUROPEAN NURSES IN DIABETES (A Company Limited by Guarantee)
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023
17. Analysis of net assets between funds (continued)
Analysis of net assets between funds - prior year
| Tangible fixed assets Current assets Creditors due within one year Total |
Unrestricted funds 2022 £ 1,643 1,161,163 (21,111) 1,141,695 |
Total funds 2022 £ 1,643 1,161,163 (21,111) 1,141,695 |
|---|---|---|
18. Related party transactions
The charity has not entered into any related party transaction during the year, nor are there any outstanding balances owing between related parties and the charity at 31 December 2023.
19. Controlling party
The charity is under control of the Trustees, as a body.
Page 21